210 related articles for article (PubMed ID: 37042946)
1. Cannabidiol in the acute phase of febrile infection-related epilepsy syndrome (FIRES).
Fetta A; Crotti E; Campostrini E; Bergonzini L; Cesaroni CA; Conti F; Di Pisa V; Gentile V; Mondardini MC; Vezzoli C; Giordano L; Cordelli DM
Epilepsia Open; 2023 Jun; 8(2):685-691. PubMed ID: 37042946
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.
Gofshteyn JS; Wilfong A; Devinsky O; Bluvstein J; Charuta J; Ciliberto MA; Laux L; Marsh ED
J Child Neurol; 2017 Jan; 32(1):35-40. PubMed ID: 27655472
[TBL] [Abstract][Full Text] [Related]
3. Treatment of new onset refractory status epilepticus/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult.
Girardin ML; Flamand T; Roignot O; Abi Warde MT; Mutschler V; Voulleminot P; Guillot M; Dinkelacker V; De Saint-Martin A
Epilepsia; 2023 Jun; 64(6):e87-e92. PubMed ID: 36961094
[TBL] [Abstract][Full Text] [Related]
4. Myoclonic super-refractory status epilepticus with favourable evolution in a teenager with FIRES: Is the association of vagus nerve stimulation and cannabidiol effective?
Bonardi CM; Furlanis GM; Toldo I; Guarrera B; Luisi C; Pettenazzo A; Nosadini M; Boniver C; Sartori S; Landi A
Brain Dev; 2023 May; 45(5):293-299. PubMed ID: 36725381
[TBL] [Abstract][Full Text] [Related]
5. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
Caputo D; Iorio R; Vigevano F; Fusco L
Eur J Paediatr Neurol; 2018 Jan; 22(1):182-185. PubMed ID: 29203057
[TBL] [Abstract][Full Text] [Related]
6. Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop.
Koh S; Wirrell E; Vezzani A; Nabbout R; Muscal E; Kaliakatsos M; Wickström R; Riviello JJ; Brunklaus A; Payne E; Valentin A; Wells E; Carpenter JL; Lee K; Lai YC; Eschbach K; Press CA; Gorman M; Stredny CM; Roche W; Mangum T
Epilepsia Open; 2021 Mar; 6(1):62-72. PubMed ID: 33681649
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol in refractory status epilepticus: A review of clinical experiences.
Duda J; Reinert JP
Seizure; 2022 Dec; 103():115-119. PubMed ID: 36399869
[TBL] [Abstract][Full Text] [Related]
8. Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.
Hon KL; Leung AKC; Torres AR
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):128-135. PubMed ID: 29745347
[TBL] [Abstract][Full Text] [Related]
9. Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy.
Golub V; Ramakrishnan S; Reddy DS
Exp Neurol; 2023 Feb; 360():114294. PubMed ID: 36493860
[TBL] [Abstract][Full Text] [Related]
10. Febrile infection-related Epilepsy Syndrome (FIRES): a severe encephalopathy with status epilepticus. Literature review and presentation of two new cases.
Pavone P; Corsello G; Raucci U; Lubrano R; Parano E; Ruggieri M; Greco F; Marino S; Falsaperla R
Ital J Pediatr; 2022 Dec; 48(1):199. PubMed ID: 36527084
[TBL] [Abstract][Full Text] [Related]
11. Vagus nerve stimulation for super-refractory status epilepticus in febrile infection-related epilepsy syndrome: a pediatric case report and literature review.
Luo T; Wang Y; Lu G; Zhou Y; Wang Y
Childs Nerv Syst; 2022 Jul; 38(7):1401-1404. PubMed ID: 34762158
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
Reddy DS
Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
[TBL] [Abstract][Full Text] [Related]
13. Successful Treatment of Pediatric FIRES With Anakinra.
Yang JH; Nataraj S; Sattar S
Pediatr Neurol; 2021 Jan; 114():60-61. PubMed ID: 33227629
[No Abstract] [Full Text] [Related]
14. Severe, Refractory Seizures: New-Onset Refractory Status Epilepticus and Febrile Infection-Related Epilepsy Syndrome.
Carson R; Stredny CM
Med Clin North Am; 2024 Jan; 108(1):201-213. PubMed ID: 37951651
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
Golub V; Reddy DS
Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
[TBL] [Abstract][Full Text] [Related]
17. Febrile Infection-Related Epilepsy Syndrome (FIRES): A Literature Review and Case Study.
Fox K; Wells ME; Tennison M; Vaughn B
Neurodiagn J; 2017; 57(3):224-233. PubMed ID: 28898171
[TBL] [Abstract][Full Text] [Related]
18. Non-convulsive status epilepticus in the setting of cannabidiol adjunctive therapy.
Tanwir A; Szabó CÁ
Epileptic Disord; 2022 Aug; 24(4):713-718. PubMed ID: 35770762
[TBL] [Abstract][Full Text] [Related]
19. Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series.
Aledo-Serrano A; Hariramani R; Gonzalez-Martinez A; Álvarez-Troncoso J; Toledano R; Bayat A; Garcia-Morales I; Becerra JL; Villegas-Martínez I; Beltran-Corbellini A; Gil-Nagel A
Seizure; 2022 Aug; 100():51-55. PubMed ID: 35759951
[TBL] [Abstract][Full Text] [Related]
20. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives.
Gaspard N; Hirsch LJ; Sculier C; Loddenkemper T; van Baalen A; Lancrenon J; Emmery M; Specchio N; Farias-Moeller R; Wong N; Nabbout R
Epilepsia; 2018 Apr; 59(4):745-752. PubMed ID: 29476535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]